|
|
|
Exhibit 1.1
|
|
|
|
|
|
|
|
EXECUTION VERSION
|
|
|
|
|
|
C L I F F O R
D
|
|
CLIFFORD CHANCE US LLP
|
|
C H A N C E
|
|
|
|
|
|
|
____________________
UNDERWRITING
AGREEMENT
Dated as of December 5,
2006
among
SIMON PROPERTY GROUP,
L.P.
and
UBS SECURITIES LLC
and
GREENWICH CAPITAL MARKETS,
INC.
and
MERRILL LYNCH, PIERCE, FENNER
& SMITH INCORPORATED
and
WACHOVIA CAPITAL MARKETS,
LLC
____________________
SIMON PROPERTY GROUP,
L.P.
(a Delaware limited partnership)
$600,000,000 5.00% Notes due
2012
$650,000,000 5.25% Notes due
2016
UNDERWRITING AGREEMENT
December 5, 2006
UBS SECURITIES LLC
GREENWICH CAPITAL MARKETS, INC.
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
WACHOVIA CAPITAL MARKETS, LLC
as Representatives of the several
Underwriters
c/o UBS Securities LLC
677 Washington Blvd.
Stamford, CT 06901
Ladies and Gentlemen:
Simon Property Group, L.P., a
Delaware limited partnership (the “Operating
Partnership”), confirms its agreement with UBS Securities LLC
(“UBS”), Greenwich Capital Markets, Inc. (“RBS
Greenwich”), Merrill Lynch, Pierce, Fenner & Smith
Incorporated (“Merrill Lynch”) and Wachovia Capital
Markets, LLC (“Wachovia”) and each of the Underwriters
named in Schedule 1 hereto (collectively, the
“Underwriters,” which term shall also include any
Underwriter substituted as hereinafter provided in Section 10
hereof), for whom the Underwriters are acting as Representatives
(in such capacity, the “Representatives”), with respect
to the issue and sale by the Operating Partnership and the purchase
by the Underwriters, acting severally and not jointly, of the
respective principal amounts set forth in said
Schedule 1 of $600,000,000 aggregate principal amount
of its 5.00% senior unsecured notes due 2012 (the “2012
Notes”) and $650,000,000 aggregate principal amount of its
5.25% senior unsecured notes due 2016 (the “2016 Notes”
and, together with the 2012 Notes, the
“Notes”).
The Notes shall be issued under an
indenture, dated as of November 26, 1996 (the “Original
Indenture”), between the Operating Partnership and The Bank
of New York (successor to The Chase Manhattan Bank), as trustee
(the “Trustee”). The title, aggregate principal
amount, rank, interest rate or formula and timing of payments
thereof, stated maturity date, redemption and/or repayment
provisions, sinking fund requirements and any other variable terms
of the Notes shall be established by or pursuant to a seventeenth
supplemental indenture to the Original Indenture (as so
supplemented, and as the same may be amended or further
supplemented from time to time, the “Indenture”) to be
entered into between the Operating Partnership and the Trustee on
or prior to the Closing Time (as defined in Section 2(b)).
Notes issued in book-entry form shall be issued to Cede & Co.
as nominee of The Depository Trust Company (“DTC”)
pursuant to a letter agreement, to be dated as of the Closing Time
(the “DTC Agreement”), among the Operating Partnership,
the Trustee and DTC.
The Operating Partnership
understands that the Underwriters propose to make a public offering
of the Notes on the terms and in the manner set forth herein and as
soon as the Representatives deem advisable after this Agreement has
been executed and delivered and the Indenture has been qualified
under the Trust Indenture Act of 1939, as amended (the “1939
Act”).
The Operating Partnership and Simon
Property Group, Inc. a Delaware corporation and the sole general
partner of the Operating Partnership (the “Company”)
have jointly prepared and filed with the Securities and Exchange
Commission (the “Commission”) an automatic shelf
registration statement on Form S-3 (No. 333-132513 and
333-132513-01), including the related preliminary prospectus or
prospectuses, which registration statement became effective upon
filing under Rule 462(e) of the rules and regulations of the
Commission (the “1933 Act Regulations”) under the
Securities Act of 1933, as amended (the “1933
Act”). Such registration statement covers the
registration of the Notes under the 1933 Act.
Promptly after execution and
delivery of this Agreement, the Operating Partnership will prepare
and file with the Commission a prospectus supplement in accordance
with the provisions of Rule 430B (“Rule 430B”) of the
1933 Act Regulations and paragraph (b) of Rule 424 (“Rule
424(b)”) of the 1933 Act Regulations, and deliver such
prospectus to the Underwriters, for use by the Underwriters in
connection with their solicitation of purchases of, or offering of,
the Notes. Any information included in such prospectus
supplement that was omitted from such registration statement at the
time it became effective but that is deemed to be part of and
included in such registration statement pursuant to Rule 430B is
referred to as “Rule 430B Information.” Each
prospectus supplement used in connection with the offering of the
Notes that omitted Rule 430B Information is herein called a
“preliminary prospectus supplement.” Such
registration statement, at any given time, including the amendments
thereto to such time, the exhibits and any schedules thereto at
such time, the documents incorporated by reference therein pursuant
to Item 12 of Form S-3 under the 1933 Act at such time and the
documents otherwise deemed to be a part thereof or included therein
by the 1933 Act Regulations, is herein called the
“Registration Statement.” The Registration
Statement at the time it originally became effective is herein
called the “Original Registration Statement.” The
final prospectus supplement in the form first furnished to the
Underwriters for use in connection with the offering of the Notes,
including the documents incorporated by reference therein pursuant
to Item 12 of Form S-3 under the 1933 Act at the time of the
execution of this Agreement and any prospectus supplement that
forms a part thereof, is herein called the “Prospectus
Supplement.” For purposes of this Agreement, all
references to the Registration Statement, any preliminary
prospectus supplement, the Prospectus Supplement or any amendment
or supplement to any of the foregoing shall be deemed to include
the copy filed with the Commission pursuant to its Electronic Data
Gathering, Analysis and Retrieval (“EDGAR”)
system. Capitalized terms used but not otherwise defined
shall have the meanings given to those terms in the Prospectus
Supplement.
All references in this Agreement to
financial statements and schedules and other information which is
“contained,” “included” or
“stated” in the Registration Statement, any preliminary
prospectus supplement or the Prospectus Supplement (or other
references of like import) shall be deemed to mean and include all
such financial statements and schedules and other information which
is incorporated by reference in or otherwise deemed by the 1933 Act
Regulations to be a part of or included in the Registration
Statement, any preliminary prospectus supplement or the Prospectus
Supplement, as the case may be; and all references in this
Agreement to amendments or supplements to the Registration
Statement, any preliminary prospectus or the Prospectus shall be
deemed to mean and include the filing of any document under the
Securities Exchange Act of 1934, as amended (the “1934
Act”) which is incorporated by reference in or otherwise
deemed by the 1933 Act Regulations to be a part of or included in
the Registration Statement, such preliminary prospectus supplement
or the Prospectus Supplement, as the case may be.
2
The term “subsidiary”
means a corporation, partnership or other entity, a majority of the
outstanding voting stock, partnership interests or other equity
interests, as the case may be, of which is owned or controlled,
directly or indirectly, by the Operating Partnership and/or the
Company, or by one or more other subsidiaries of the Operating
Partnership and/or the Company.
SECTION
1.
Representations and Warranties .
(a)
Representations and Warranties by the Operating Partnership.
The Operating Partnership represents and warrants to each
Underwriter, as of the date hereof, as of the Applicable Time (as
defined below) and as of the Closing Time (in each case, a
“Representation Date”), and agrees with each
Underwriter, as follows:
(1)
Status as a Well-Known Seasoned Issuer. (A) At the time of
filing the Original Registration Statement, (B) at the time of the
most recent amendment thereto for the purposes of complying with
Section 10(a)(3) of the 1933 Act (whether such amendment was by
post-effective amendment, incorporated report filed pursuant to
Section 13 or 15(d) of the 1934 Act or form of prospectus), (C) at
the time the Company or the Operating Partnership or any person
acting on their behalf (within the meaning, for this clause only,
of Rule 163(c) of the 1933 Act Regulations) made any offer relating
to the Notes in reliance on the exemption of Rule 163 of the 1933
Act Regulations and (D) at the date hereof, each of the Company and
the Operating Partnership was and is a “well-known seasoned
issuer” as defined in Rule 405 of the 1933 Act Regulations
(“Rule 405”), including not having been and not being
an “ineligible issuer” as defined in Rule
405. The Registration Statement is an “automatic
shelf registration statement,” as defined in Rule 405, and
the Notes, since their registration on the Registration Statement,
have been and remain eligible for registration by the Operating
Partnership on a Rule 405 “automatic shelf registration
statement.” Neither the Company nor the Operating
Partnership has received from the Commission any notice pursuant to
Rule 401(g)(2) of the 1933 Act Regulations objecting to the use of
the automatic shelf registration statement form.
At the time of filing the Original
Registration Statement, at the earliest time thereafter that the
Company or the Operating Partnership or another offering
participant made a bona fide offer (within the meaning of
Rule 164(h)(2) of the 1933 Act Regulations) of the Notes and at the
date hereof, each of the Company and the Operating Partnership was
not and is not an “ineligible issuer,” as defined in
Rule 405.
(2)
The Registration Statement . The Original Registration
Statement became effective upon filing under Rule 462(e) of the
1933 Act Regulations (“Rule 462(e)”) on March 17, 2006,
and any post-effective amendment thereto also became effective upon
filing under Rule 462(e). No stop order suspending the
effectiveness of the Registration Statement has been issued under
the 1933 Act and no proceedings for that purpose have been
instituted or are pending or, to the knowledge of the Company or
the Operating Partnership, are contemplated by the Commission, and
any request on the part of the Commission for additional
information has been complied with.
Any offer that is a written
communication relating to the Notes made prior to the filing of the
Original Registration Statement by the Company or the Operating
Partnership or any person acting on their behalf (within the
meaning, for this paragraph only, of Rule 163(c) of the 1933 Act
Regulations) has been filed with the Commission in accordance with
the exemption provided by Rule 163 of the 1933 Act Regulations
(“Rule 163”) and otherwise complied with the
requirements of Rule 163, including without limitation the
legending requirement, to qualify such offer for the exemption from
Section 5(c) of the 1933 Act provided by Rule 163.
3
At the respective times the Original
Registration Statement and each amendment thereto became effective,
at each deemed effective date with respect to the Underwriters
pursuant to Rule 430B(f)(2) of the 1933 Act Regulations and at the
Closing Time, the Registration Statement complied and will comply
in all material respects with the requirements of the 1933 Act and
the 1933 Act Regulations and the 1939 Act and the rules and
regulations of the Commission under the 1939 Act (the “1939
Act Regulations”), and did not and will not contain an untrue
statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements
therein not misleading; provided , that this representation,
warranty and agreement shall not apply to statements in or
omissions from the Registration Statement made in reliance upon and
in conformity with information furnished to the Operating
Partnership in writing by any Underwriter through UBS expressly for
use in the Registration Statement.
(3)
The Prospectus Supplement . The Prospectus Supplement
and any amendments or supplements thereto, at the time the
Prospectus Supplement or any such amendment or supplement was
issued, do not, and at the Closing Time shall not, include an
untrue statement of a material fact or omit to state a material
fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not
misleading; provided , that this representation, warranty
and agreement shall not apply to statements in or omissions from
the Prospectus Supplement or any amendments or supplements thereto
made in reliance upon and in conformity with information furnished
to the Operating Partnership in writing by any Underwriter through
UBS expressly for use in such Prospectus Supplement or any
amendments or supplements thereto.
Each preliminary prospectus
supplement (including the prospectus or prospectuses filed as part
of the Original Registration Statement or any amendment thereto,
the Prospectus Supplement) or any amendment or supplement thereto
complied when so filed in all material respects with the 1933 Act
Regulations and each preliminary prospectus supplement and the
Prospectus Supplement delivered to the Underwriters for use in
connection with this offering was identical to the electronically
transmitted copies thereof filed with the Commission pursuant to
EDGAR, except to the extent permitted by Regulation S-T.
(4)
Disclosure at Time of Sale. As of the Applicable Time,
neither (x) the Issuer General Use Free Writing Prospectus(es) (as
defined below) issued at or prior to the Applicable Time or the
Statutory Prospectus (as defined below), considered together
(collectively, the “General Disclosure Package”), nor
(y) any individual Issuer Limited Use Free Writing Prospectus, when
considered together with the General Disclosure Package, included
any untrue statement of a material fact or omitted to state any
material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not
misleading. The preceding sentence does not apply to
statements in or omissions from the General Disclosure Package or
any Issuer Limited Use Free Writing Prospectus based upon or in
conformity with written information furnished to the Operating
Partnership by any Underwriter through UBS specifically for use
therein.
As of the time of the filing of the
Final Term Sheet (as defined in Section 3(e)), the General
Disclosure Package, when considered together with the Final Term
Sheet, did not include any untrue statement of a material fact or
omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances under which
they were made, not misleading. The preceding sentence does not
apply to statements in or omissions from the General Disclosure
Package based upon or in conformity with written information
furnished to the Operating Partnership by any Underwriter through
the Representatives specifically for use therein.
4
Each Issuer Free Writing Prospectus,
as of its issue date and at all subsequent times through the
completion of the public offer and sale of the Notes or until any
earlier date that the Operating Partnership notified or notifies
UBS as described in Section 3(d), did not, does not and will not
include any information that conflicted, conflicts or will conflict
with the information contained in the Registration Statement or the
Prospectus Supplement, including any document incorporated by
reference therein and any preliminary or other prospectus
supplement deemed to be a part thereof that has not been superseded
or modified. The preceding sentence does not apply to statements in
or omissions from any Issuer Free Writing Prospectus based upon or
in conformity with written information furnished to the Operating
Partnership by any Underwriter through the Representatives
specifically for use therein.
The representations and warranties
in this subsection shall not apply to statements in or omissions
from any Issuer Free Writing Prospectus made in reliance upon and
in conformity with written information furnished to the Operating
Partnership by any Underwriter through UBS expressly for use
therein.
As used in this subsection and
elsewhere in this Agreement:
“Applicable Time” means
3:15 p.m. (Eastern Time) on December 5, 2006 or such other time as
agreed by the Operating Partnership and UBS.
“Issuer Free Writing
Prospectus” means any “issuer free writing
prospectus,” as defined in Rule 433 of the 1933 Act
Regulations (“Rule 433”), relating to the Notes that
(i) is required to be filed with the Commission by the Operating
Partnership, (ii) is a “road show that is a written
communication” within the meaning of Rule 433(d)(8)(i),
whether or not required to be filed with the Commission or (iii) is
exempt from filing pursuant to Rule 433(d)(5)(i) because it
contains a description of the Notes or of the offering that does
not reflect the final terms, in each case in the form filed or
required to be filed with the Commission or, if not required to be
filed, in the form retained in the Operating Partnership’s
records pursuant to Rule 433(g).
“Issuer General Use Free
Writing Prospectus” means any Issuer Free Writing Prospectus
that is intended for general distribution to prospective investors,
as evidenced by its being specified in Schedule 2
hereto.
“Issuer Limited Use Free
Writing Prospectus” means any Issuer Free Writing Prospectus
that is not an Issuer General Use Free Writing
Prospectus.
“Statutory Prospectus”
as of any time means the prospectus relating to the Notes that is
included in the Registration Statement immediately prior to that
time, including any document incorporated by reference therein and
any preliminary or other prospectus deemed to be a part
thereof.
(5)
Incorporated Documents. The Prospectus Supplement
shall incorporate by reference the most recent Annual Report of the
Company and the Operating Partnership on Form 10-K, as
amended, filed with the Commission and each Quarterly Report of the
Company and the Operating Partnership on Form 10-Q and each Current
Report of the Company and the Operating Partnership on Form 8-K
filed with the Commission since the filing of the Annual
Report. The documents incorporated or deemed to be
incorporated by reference in the preliminary prospectus supplement
or the Prospectus Supplement, at the time they were or hereafter
are filed with the Commission, complied and shall comply in all
material respects with the requirements of the 1934 Act and the
rules and regulations of the Commission thereunder (the
5
“1934 Act Regulations”)
and, when read together with the other information in the
Prospectus Supplement, at (a) the time the Original
Registration Statement became effective, (b) the earlier of the
time the preliminary prospectus supplement or the Prospectus
Supplement was first used and the date and time of the first
contract of sale of Notes in this offering, and (c) the
Closing Time, did not and shall not include an untrue statement of
a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein, in the
light of the circumstances under which they were made, not
misleading.
(6)
Pending Proceedings and Examinations. The
Registration Statement is not the subject of a pending proceeding
or examination under Section 8(d) or 8(e) of the 1933 Act, and the
Operating Partnership is not the subject of a pending proceeding
under Section 8A of the 1933 Act in connection with the offering of
the Notes.
(7)
Independent Accountants . The accountants who
certified the financial statements and supporting schedules
included, or incorporated by reference, in the Prospectus
Supplement were independent registered public accountants with
respect to the Company and its subsidiaries and the Operating
Partnership and its subsidiaries, and the current accountants of
the Company and the Operating Partnership are independent
registered public accountants with respect to the Company and its
subsidiaries and the Operating Partnership and its subsidiaries, in
each case, as required by the 1933 Act and the rules and
regulations promulgated by the Commission thereunder.
(8)
Financial Statements . The financial statements
included, or incorporated by reference, in the Registration
Statement, General Disclosure Package and the Prospectus
Supplement, together with the related schedules and notes, as well
as those financial statements, schedules and notes of any other
entity included therein, present fairly the financial position of
the respective entity or entities or group presented therein at the
respective dates indicated and the statement of operations,
stockholders’ equity and cash flows of such entity, as the
case may be, for the periods specified. Such financial
statements have been prepared in conformity with United States
generally accepted accounting principles (“GAAP”)
applied on a consistent basis throughout the periods
involved. The supporting schedules, if any, included, or
incorporated by reference, in the Prospectus Supplement present
fairly, in accordance with GAAP, the information stated
therein. The selected financial data, the summary financial
information and other financial information and data included, or
incorporated by reference, in the Prospectus Supplement present
fairly the information shown therein and have been compiled on a
basis consistent with that of the audited financial statements
included, or incorporated by reference, in the Prospectus
Supplement. In addition, any pro forma financial information
and the related notes thereto, if any, included, or incorporated by
reference in the Registration Statement, General Disclosure Package
or the Prospectus Supplement, as applicable, present fairly the
information shown therein, have been prepared in accordance with
the Commission’s rules and guidelines and the guidelines of
the American Institute of Certified Public Accountants
(“AICPA”) and the Public Company Accounting Oversight
Board with respect to pro forma information and have been properly
compiled on the bases described therein, and the assumptions used
in the preparation thereof are reasonable and the adjustments used
therein are appropriate to give effect to the transactions and
circumstances referred to therein. All disclosures contained
in the Registration Statement, the General Disclosure Package or
the Prospectus regarding “non-GAAP financial measures”
(as such term is defined by the rules and regulations of the
Commission) comply with Regulation G under the 1934 Act and Item 10
of Regulation S-K of the 1933 Act Regulations, to the extent
applicable.
6
(9)
Internal Accounting Controls. The Company and the
Operating Partnership each maintain a system of internal accounting
controls sufficient to provide reasonable assurance that: (a)
transactions are properly authorized; (b) assets are safeguarded
against unauthorized or improper use; (c) transactions are properly
recorded and reported as necessary to permit preparation of its
financial statements in conformity with GAAP and to maintain
accountability for assets; and (d) the recorded accountability for
assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any
differences.
(10)
Controls and Procedures. The Company and the
Operating Partnership have established and maintain disclosure
controls and procedures (as such term is defined in Rule 13a-14 and
15d-14 under the Exchange Act); such disclosure controls and
procedures are designed to ensure that material information
relating to the Company and the Operating Partnership, including
their consolidated subsidiaries, is recorded, processed, summarized
and reported, within the time periods specified in the
Commission’s rules and forms and is made known to the
Company’s Chief Executive Officer and its Chief Financial
Officer by others within those entities, as appropriate, to allow
timely decisions regarding disclosure, and such disclosure controls
and procedures are effective to perform the functions for which
they were established; the Company’s and the Operating
Partnership’s auditors and the Audit Committee of the Board
of Directors of the Company have been advised of:
(i) any significant deficiencies in the design or operation of
internal controls which could have a material effect on the
Company’s and the Operating Partnership’s ability to
record, process, summarize, and report financial data; and
(ii) any fraud, whether or not material, that involves
management or other employees who have a role in the
Company’s and the Operating Partnership’s internal
controls; any material weaknesses in internal control over
financial reporting (whether or not remedied) have been disclosed
to the Company’s and the Operating Partnership’s
auditors; and since the date of the most recent evaluation of such
disclosure controls and procedures, there have been no changes in
internal control over financial reporting or in other factors
that has materially affected, or is reasonably likely to materially
affect, internal control over financial reporting, including any
corrective actions with regard to significant deficiencies and
material weaknesses.
(11)
No Material Adverse Change in Business . Since the
respective dates as of which information is given in the
Registration Statement, General Disclosure Package or Prospectus
Supplement, except as otherwise stated therein, (a) there has
been no material adverse change in the condition, financial or
otherwise, or in the earnings, assets, business affairs or business
prospects of the Company, any subsidiary of the Company, the
Operating Partnership, any subsidiary of the Operating Partnership
(other than any Property Partnership (as defined below)) (the
Company, the Operating Partnership and such subsidiaries being
sometimes hereinafter collectively referred to as the “Simon
Entities” and individually as a “Simon Entity”),
or of any entity which owns any Property (as such term is defined
in the Prospectus Supplement) or any direct interest in any
Property (the “Property Partnerships”) whether or not
arising in the ordinary course of business, which, taken as a
whole, would be material to the Company, the Operating Partnership
and the other Simon Entities, taken as a whole (anything which,
taken as a whole, would be material to the Company, the Operating
Partnership and the other Simon Entities taken as a whole, being
hereinafter referred to as “Material;” and such a
material adverse change, a “Material Adverse Effect”),
(b) no casualty loss or condemnation or other adverse event
with respect to the Properties (as such term is defined in the
Prospectus Supplement) has occurred which would be Material,
(c) there have been no transactions or acquisitions entered
into by the Simon Entities, other than those in the ordinary course
of business, which would be Material, (d) except for
distributions in amounts per unit that are consistent with past
practices, there has been no distribution of any kind declared,
paid or made by the Operating Partnership on any of its respective
general, limited and/or preferred partnership interests,
(e) there has been no change in
7
the capital stock of the corporate
Simon Entities or in the partnership interests of the Operating
Partnership or any Property Partnership, and (f) there has
been no increase in the indebtedness of the Simon Entities, the
Property Partnerships or the Properties which would be
Material.
(12)
Good Standing of the Company . The Company has been
duly organized and is validly existing as a corporation in good
standing under the laws of the State of Delaware and has corporate
power and authority to own, lease and operate its properties and to
conduct its business as described in the Prospectus
Supplement. The Company is duly qualified as a foreign
corporation to transact business and is in good standing in each
other jurisdiction in which such qualification is required, whether
by reason of the ownership or leasing of property or the conduct of
business, except where the failure to so qualify or be in good
standing would not result in a Material Adverse Effect.
(13)
Good Standing of the Operating Partnership . The
Operating Partnership is duly organized and validly existing as a
limited partnership in good standing under the laws of the State of
Delaware, with the requisite power and authority to own, lease and
operate its properties, to conduct the business in which it is
engaged and proposes to engage as described in the Prospectus
Supplement and to enter into and perform its obligations under this
Agreement. The Operating Partnership is duly qualified or
registered as a foreign partnership and is in good standing in each
jurisdiction in which such qualification or registration is
required, whether by reason of the ownership or leasing of property
or the conduct of business, except where the failure to so qualify
or register would not have a Material Adverse Effect. The
Company is the sole general partner of the Operating
Partnership. The amended and restated agreement of limited
partnership of the Operating Partnership (the “OP Partnership
Agreement”) is in full force and effect in the form in which
it was filed as an exhibit to the Operating Partnership’s
Annual Report on Form 10-K for the year ended December 31, 2000, as
amended by the Amended and Restated Supplement dated as of October
14, 2004 and except for subsequent amendments relating to the
admission of new partners to the Operating Partnership.
(14)
Good Standing of Simon Entities . Each of the Simon
Entities other than the Company and the Operating Partnership has
been duly organized and is validly existing as a corporation,
limited partnership, limited liability company or other entity, as
the case may be, in good standing under the laws of the state of
its jurisdiction of incorporation or organization, as the case may
be, with the requisite power and authority to own, lease and
operate its properties, and to conduct the business in which it is
engaged or proposes to engage as described in the Prospectus
Supplement. Each such entity is duly qualified or registered
as a foreign corporation, limited partnership or limited liability
company or other entity, as the case may be, to transact business
and is in good standing in each jurisdiction in which such
qualification or registration is required, whether by reason of the
ownership or leasing of property or the conduct of business, except
where the failure to so qualify or register would not have a
Material Adverse Effect. Except as otherwise stated in the
Prospectus Supplement, all of the issued and outstanding capital
stock or other equity interests of each such entity have been duly
authorized and validly issued and are fully paid and
non-assessable, have been offered and sold in compliance with all
applicable laws (including without limitation, federal or state
securities laws) and are owned by the Company or the Operating
Partnership, directly or through subsidiaries, in each case free
and clear of any security interest, mortgage, pledge, lien,
encumbrance, claim or equity (collectively,
“Liens”). No shares of capital stock or other
equity interests of such entities are reserved for any purpose, and
there are no outstanding securities convertible into or
exchangeable for any capital stock or other equity interests of
such entities and no outstanding options, rights (preemptive or
otherwise) or warrants to purchase or to subscribe for shares of
such capital stock or any other securities of such entities, except
as disclosed in the Prospectus Supplement. No such shares
of
8
capital stock or other equity
interests of such entities were issued in violation of preemptive
or other similar rights arising by operation of law, under the
charter or by-laws of such entity or under any agreement to which
any Simon Entity is a party.
(15)
Capitalization . The issued and outstanding units of
general, limited and/or preferred partner interests of the
Operating Partnership are as set forth in the Operating
Partnership’s Quarterly Report on Form 10-Q filed on November
13, 2006 (except for subsequent issuances thereof, if any,
contemplated under this Agreement or referred to in the Prospectus
Supplement).
(16)
Authorization of Underwriting Agreement . This
Agreement has been duly authorized, executed and delivered by the
Company and the Operating Partnership and, assuming due
authorization, execution and delivery by or on behalf of the
Underwriters, shall constitute a valid and legally binding
agreement of the Company and the Operating Partnership, enforceable
against the Company and the Operating Partnership in accordance
with its terms except (a) to the extent that enforceability
thereof may be limited by (i) bankruptcy, insolvency,
reorganization, moratorium, fraudulent conveyance or other similar
laws now or hereafter in effect relating to creditors’ rights
generally and (ii) general principles of equity (regardless of
whether considered at law or in equity); and (b) to the extent
that rights to indemnification and contribution contained in this
Agreement may be limited by state or federal securities laws or
public policy.
(17)
Authorization of the Indenture . For the Notes being
sold pursuant to this Agreement, the Indenture has been, or prior
to the issuance of the Notes thereunder shall have been, duly
authorized, executed and delivered by the Operating Partnership
and, upon such authorization, execution and delivery, shall
constitute a valid and legally binding agreement of the Operating
Partnership, enforceable against the Operating Partnership, in
accordance with its terms, except as the enforcement thereof may be
limited by (a) bankruptcy, insolvency, reorganization,
moratorium or other similar laws relating to or affecting
creditors’ rights generally, (b) general equitable
principles (regardless of whether enforcement is considered in a
proceeding in equity or at law), (c) requirements that a claim
with respect to any Notes issued under the Indenture that are
payable in a foreign or composite currency (or a foreign or
composite currency judgment in respect of such claim) be
converted into U.S. dollars at a rate of exchange prevailing on a
date determined pursuant to applicable law, or
(d) governmental authority to limit, delay or prohibit the
making of payments outside the United States. The Indenture
has been duly qualified under the 1939 Act and conforms, in all
material respects, to the descriptions thereof contained in the
Prospectus Supplement.
(18)
Authorization of the Notes . The Notes being sold
pursuant to this Agreement have been duly authorized by the
Operating Partnership for issuance and sale pursuant to this
Agreement, and, at the Closing Time, will have been duly executed
by Operating Partnership. Such Notes, when issued and
authenticated in the manner provided for in the applicable
Indenture and delivered by the Operating Partnership pursuant to
this Agreement against payment of the consideration therefor
specified in this Agreement, shall constitute valid and legally
binding, unsecured obligations of the Operating Partnership,
enforceable against the Operating Partnership, in accordance with
their terms, except as the enforcement thereof may be limited by
bankruptcy, insolvency, reorganization, moratorium or other similar
laws relating to or affecting creditors’ rights generally or
by general equitable principles, and except further as enforcement
thereof may be limited by (a) requirements that a claim with
respect to any Notes denominated other than in U.S. dollars (or a
foreign or composite currency judgment in respect of such
claim) be converted into U.S. dollars at a rate of exchange
prevailing on a date determined pursuant to applicable law or
(b) governmental authority to limit, delay or prohibit the
making of
9
payments outside the United
States. Such Notes shall be in the form contemplated by, and
each registered holder thereof shall be entitled to the benefits
of, the applicable Indenture. Such Notes rank and shall rank
equally with all unsecured indebtedness (other than subordinated
indebtedness) of the Operating Partnership that is outstanding
on a Reporting Date (as such term is defined in the Prospectus
Supplement) or that may be incurred thereafter and senior to all
subordinated indebtedness that is outstanding on a Reporting Date
or that may be incurred thereafter, except that such Notes shall be
effectively subordinate to the prior claims of each secured
mortgage lender to any specific Property which secures such
lender’s mortgage and any claims of creditors of entities
wholly or partly owned, directly or indirectly, by the Operating
Partnership.
(19)
Descriptions of the Notes and the Indenture . The
Notes being sold pursuant to this Agreement and the Indenture shall
conform in all material respects to the statements relating thereto
contained in the Prospectus Supplement and shall be in
substantially the respective forms previously delivered to the
Underwriters.
(20)
Absence of Defaults and Conflicts . None of the Simon
Entities or any Property Partnership is in violation of its
charter, by-laws, certificate of limited partnership or partnership
agreement or other organizational document, as the case may be, or
in default in the performance or observance of any obligation,
agreement, covenant or condition contained in any contract,
indenture, mortgage, deed of trust, loan or credit agreement, note,
lease or other agreement or instrument to which each entity is a
party or by which or any of them may be bound, or to which any of
its property or assets or any Property may be bound or subject
(collectively, “Agreements and Instruments”), except
for such violations (other than with respect to the charter,
by-laws, partnership agreement, or other organizational document of
such entities) or defaults that would not result in a Material
Adverse Effect. The execution, delivery and performance of
this Agreement, the Notes, the Indenture and any other agreement or
instrument entered into or issued or to be entered into or issued
by the Company or the Operating Partnership in connection with the
transactions contemplated hereby or thereby or in the Prospectus
Supplement and the consummation of the transactions contemplated
herein and in the Prospectus Supplement (including the issuance and
sale of the Notes and the use of the proceeds from the sale of the
Notes as described under the caption “Use of Proceeds”)
and compliance by each of the Company and the Operating Partnership
with its obligations hereunder and thereunder have been duly
authorized by all necessary action, and do not and shall not,
whether with or without the giving of notice or passage of time or
both, conflict with or constitute a breach of, or default or
Repayment Event (as defined below) under, or result in the creation
or imposition of any lien, charge or encumbrance upon any assets,
properties or operations of the Operating Partnership or any other
Simon Entity or any Property Partnership pursuant to, any
Agreements and Instruments, except for such conflicts, breaches,
defaults, Repayment Events or liens, charges or encumbrances that,
singly or in the aggregate, would not result in a Material Adverse
Effect, nor shall such action result in any violation of the
provisions of the OP Partnership Agreement or certificate of
limited partnership of the Operating Partnership or the
organizational documents of any other Simon Entity or any
applicable law, statute, rule, regulation, judgment, order, writ or
decree of any government, government instrumentality or court,
domestic or foreign, having jurisdiction over the Operating
Partnership, any other Simon Entity or any Property Partnership or
any of their assets, properties or operations, except for such
violations (other than with respect to the charter, by-laws,
partnership agreement, or other organizational document of such
entities) that would not have a Material Adverse Effect. As
used herein, a “Repayment Event” means any event or
condition which gives the holder of any note, debenture or other
evidence of indebtedness (or any person acting on such
holder’s behalf) the right to require the repurchase,
redemption or repayment of all or a material portion of such
indebtedness by the Operating Partnership, any other Simon Entity
or any Property Partnership.
10
(21)
Absence of Proceedings . Except as described in the
Prospectus Supplement, there is no action, suit, proceeding,
inquiry or investigation before or by any court or governmental
agency or body, domestic or foreign, now pending, or to the
knowledge of the Operating Partnership threatened against or
affecting the Operating Partnership, any other Simon Entity, or any
Property Partnership or any officer or director of the Operating
Partnership, except such as would not reasonably be expected to
result in a Material Adverse Effect, or which might reasonably be
expected to materially and adversely affect the assets, properties
or operations thereof or the consummation of this Agreement, the
Indenture or the transactions contemplated herein or therein or the
performance by the Operating Partnership of its obligations
hereunder. The aggregate of all pending legal or governmental
proceedings to which the Operating Partnership or any other Simon
Entity, or any Property Partnership is a party or of which any of
their respective assets, properties or operations is the subject
which are not described in the Prospectus Supplement including
ordinary routine litigation incidental to the business, could not
reasonably be expected to result in a Material Adverse
Effect.
(22)
REIT Qualification . At all times since January 1,
1973, the Company (including as Corporate Property Investors, a
Massachusetts business trust) has been, and upon the sale of the
applicable Notes, the Company shall continue to be, organized and
operated in conformity with the requirements for qualification and
taxation as a real estate investment trust under the Code, and its
current and proposed methods of operation shall enable it to
continue to meet the requirements for qualification and taxation as
a real estate investment trust under the Code.
(23)
Investment Company Act . Each of the Operating
Partnership, the other Simon Entities and the Property Partnerships
is not, and upon the issuance and sale of the Notes as herein
contemplated and the application of the net proceeds therefrom as
described in the Prospectus Supplement shall not be, an
“investment company” within the meaning of the
Investment Company Act of 1940, as amended (the “1940
Act”).
(24)
Absence of Further Requirements . No filing with, or
authorization, approval, consent, license, order, registration,
qualification or decree of, any court or governmental authority or
agency or any other entity or person is necessary or required for
the performance by the Operating Partnership of its obligations
under this Agreement, the Indenture or in connection with the
transactions contemplated under this Agreement or the Indenture,
except such as have been already obtained under the 1933 Act or the
1933 Act Regulations or as may be required under state securities
laws or under the by-laws and rules of the National Association of
Securities Dealers, Inc. (the “NASD”).
(25)
Possession of Licenses and Permits . The Operating
Partnership and the other Simon Entities and each Property
Partnership possess such permits, licenses, approvals, consents and
other authorizations (collectively, “Governmental
Licenses”) issued by the appropriate federal, state, local or
foreign regulatory agencies or bodies necessary to conduct the
business now operated by them except for such Governmental Licenses
the failure to obtain would not, singly or in the aggregate, result
in a Material Adverse Effect. The Operating Partnership and
the other Simon Entities and each Property Partnership are in
compliance with the terms and conditions of all such Governmental
Licenses, except where the failure so to comply would not, singly
or in the aggregate, result in a Material Adverse Effect. All
of the Governmental Licenses are valid and in full force and
effect, except where the invalidity of such Governmental Licenses
or the failure of such Governmental Licenses to be in full force
and effect would not result in a
11
Material Adverse Effect. None
of the Operating Partnership, any of the other Simon Entities or
any Property Partnership has received any notice of proceedings
relating to the revocation or modification of any such Governmental
Licenses which, singly or in the aggregate, if the subject of an
unfavorable decision, ruling or finding, would result in a Material
Adverse Effect.
(26)
Title to Property . The Operating Partnership, the
other Simon Entities and the Property Partnerships have good and
marketable title to the Properties free and clear of Liens, except
(a) as otherwise stated in the Prospectus Supplement, or
referred to in any title policy for such Property, or
(b) those which do not, singly or in the aggregate, Materially
(i) affect the value of such property or (ii) interfere
with the use made and proposed to be made of such property by the
Operating Partnership, any other Simon Entity or any Property
Partnership. All leases and subleases under which the
Operating Partnership, any other Simon Entity or any Property
Partnerships hold properties are in full force and effect, except
for such which would not have a Material Adverse Effect. None
of the Operating Partnership, the other Simon Entities or the
Property Partnerships has received any notice of any Material claim
of any sort that has been asserted by anyone adverse to the rights
of the Operating Partnership, any other Simon Entity or the
Property Partnerships under any material leases or subleases, or
affecting or questioning the rights of the Operating Partnership,
such other Simon Entity or the Property Partnerships of the
continued possession of the leased or subleased premises under any
such lease or sublease, other than claims that would not have a
Material Adverse Effect. All liens, charges, encumbrances,
claims or restrictions on or affecting any of the Properties and
the assets of any Simon Entity or any Property Partnership which
are required to be disclosed in the Prospectus Supplement are
disclosed therein. None of the Simon Entities, the Property
Partnerships or any tenant of any of the Properties is in default
under any of the ground leases (as lessee) or space leases (as
lessor or lessee, as the case may be) relating to, or any of the
mortgages or other security documents or other agreements
encumbering or otherwise recorded against, the Properties, and the
Operating Partnership knows of no event which, but for the passage
of time or the giving of notice, or both, would constitute a
default under any of such documents or agreements, in each case,
other than such defaults that would not have a Material Adverse
Effect. No tenant under any of the leases, pursuant to which
the Operating Partnership or any Property Partnership, as lessor,
leases its Property, has an option or right of first refusal to
purchase the premises demised under such lease, the exercise of
which would have a Material Adverse Effect. Each of the
Properties complies with all applicable codes, laws and regulations
(including, without limitation, building and zoning codes, laws and
regulations and laws relating to access to the Properties), except
for such failures to comply that would not in the aggregate have a
Material Adverse Effect. The Operating Partnership has no
knowledge of any pending or threatened condemnation proceeding,
zoning change, or other proceeding or action that will in any
manner affect the size of, use of, improvements on, construction on
or access to, the Properties, except such proceedings or actions
that would not have a Material Adverse Effect.
(27)
Environmental Laws . Except as otherwise stated in the
Prospectus Supplement and except such violations as would not,
singly or in the aggregate, result in a Material Adverse Effect,
(a) none of the Operating Partnership, the other Simon
Entities or any Property Partnership is in violation of any
federal, state, local or foreign statute, law, rule, regulation,
ordinance, code, policy or rule of common law and any judicial or
administrative interpretation thereof including any judicial or
administrative order, consent, decree of judgment, relating to
pollution or protection of human health, the environment
(including, without limitation, ambient air, surface water,
groundwater, land surface or subsurface strata) including,
without limitation, laws and regulations relating to the release or
threatened release of chemicals, pollutants, contaminants, wastes,
toxic substances, hazardous substances, petroleum or petroleum
products (collectively, “Hazardous Materials”) or
to the manufacture, processing, distribution, use,
12
treatment, storage, disposal,
transport or handling of Hazardous Materials (collectively,
“Environmental Laws”), (b) the Operating
Partnership, the other Simon Entities and the Property Partnerships
have all permits, authorizations and approvals required under any
applicable Environmental Laws and are each in compliance with their
requirements, (c) there are no pending or threatened
administrative, regulatory or judicial actions, suits, demands,
demand letters, claims, liens, notices of noncompliance or
violation, investigation or proceedings relating to any
Environmental Law against the Operating Partnership, any of the
other Simon Entities or the Property Partnerships and
(d) there are no events or circumstances that might reasonably
be expected to form the basis of an order for clean-up or
remediation, or an action, suit or proceeding by any private party
or governmental body or agency, against or affecting the Operating
Partnership, any of the other Simon Entities or any Property
Partnership relating to any Hazardous Materials or the violation of
any Environmental Laws.
(28)
Insurance . Each of the Operating Partnership, the
Company and the Property Partnerships maintains insurance covering
its properties, assets, operations, personnel and businesses, and
such insurance is of such type and in such amounts in accordance
with customary industry practice to protect it and its
business.
(29)
Reporting Company . Each of the Operating Partnership
and the Company is subject to the reporting requirements of Section
13 or Section 15(d) of the 1934 Act.
(30)
Investment-Grade Rating . The Notes shall have an
investment-grade rating from one or more nationally recognized
statistical rating organizations at each applicable Reporting Date,
as set forth in the Final Term Sheet.
(31)
Statistical Data and Forward-Looking Statements . The
statistical and market-related data and forward-looking statements
(within the meaning of Section 27A of the Act and Section 21E of
the 1934 Act) included in the Prospectus Supplement are based on or
derived from sources that the Operating Partnership believes to be
reliable and accurate in all material respects and represent its
good faith estimates that are made on the basis of data derived
from such sources.
(32)
Price Manipulation and Market Stabilization . Neither
the Simon Entities nor any of their respective directors, officers,
affiliates or controlling persons has taken, directly or
indirectly, any action designed, or which has constituted or might
reasonably be expected to cause or result in, under the Exchange
Act or otherwise, the stabilization or manipulation of the price of
any security of the Operating Partnership to facilitate the sale or
resale of the Notes.
(33)
Foreign Corrupt Practices Act . Neither the Operating
Partnership nor, to its knowledge, any other Simon Entity or any
Property Partnership, nor any director, officer, agent, employee or
other person associated with or acting on behalf of the Operating
Partnership or any other Simon Entity or any Property Partnership,
has used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expense relating to political
activity; made any direct or indirect unlawful payment to any
foreign or domestic government official or employee from corporate
funds; violated or is in violation of any provision of the Foreign
Corrupt Practices Act of 1977; or made any bribe, rebate, payoff,
influence payment, kickback or other unlawful payment.
(b)
Officers’ Certificates. Any certificate signed
by any officer of the Operating Partnership or any authorized
representative of the Company delivered to the Representatives or
to counsel for the Underwriters in connection with the offering of
the Notes shall be deemed a representation and warranty
13
by such entity or person, as the
case may be, to each Underwriter as to the matters covered thereby
on the date of such certificate and, unless subsequently amended or
supplemented, at each Representation Date subsequent
thereto.
SECTION
2.
Sale and Delivery to the Underwriters; Closing .
(a)
Notes. On the basis of the representations and
warranties contained herein and subject to the terms and conditions
herein set forth, the Operating Partnership agrees to sell to each
Underwriter, severally and not jointly, and each Underwriter,
severally and not jointly, agrees to purchase from the Operating
Partnership, at the price of 99.254% for the 2012 Notes and 98.757%
for the 2016 Notes, the aggregate principal amount of Notes set
forth in Schedule 1 opposite the name of such
Underwriter, plus any additional principal amount of Notes which
such Underwriter may become obligated to purchase pursuant to the
provisions of Section 11 hereof.
(b)
Payment. Payment of the purchase price for, and
delivery of, the Notes shall be made at the office of Clifford
Chance US LLP, 31 West 52 nd Street, New York, New York 10019, or at
such other place as shall be agreed upon by the Representatives and
the Operating Partnership, at 10:00 A.M. (Eastern time) on the
fifth business day after the date hereof (unless postponed in
accordance with the provisions of Section 11), or such other
time not later than ten business days after such date as shall be
agreed upon by the Representatives and the Operating Partnership
(such time and date of payment and delivery being herein called the
“Closing Time”).
Payment shall be made to the
Operating Partnership by wire transfer of same day funds payable to
the order of the Operating Partnership,